Helix Acquisition Corp. II
closed
BBOT
Capital Structure & Economics
Trust Size$150,000,000
Unit Price$10.00
Warrant Coverage-
Sponsor Promote20%
Implied Equity Architecture
Capital Allocation Baseline
Trust (100.0%)
Implied Dilution Drag
No Warrants / No Drag| Public Trust Allocation | $150,000,000 |
| Sponsor At-Risk Capital | N/A |
| Total Underwriting Discount | N/A |
| Trust Per Unit (Implied) | $10.00 |
| Sponsor Promote Allocation | 20% |
Deal Lifecycle
IPO PricedJan 18, 2024
SearchingTarget Pending
Maturation Wall
N/A
Announced Target / M&A
- Target CompanyTheRas, Inc. (dba BridgeBio Oncology Therapeutics)
- SectorBiotechnology
- Announced Deal Size$310,000,000
Board & Officers
- Eli WallaceCEO
- Cormorant Asset Management, LP(2)Officer
- Officer
- Officer
- Andrew PhillipsOfficer
- Director
- Director
- Director
- Director
- Director
Advanced Structuring Terms
| Target Sectors | Biotechnology |
Syndicate & Advisors
Interactive Deal Modeling
Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.